Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study

医学 克罗恩病 疾病 队列 队列研究 人口 自然史 内科学 环境卫生
作者
Johan M. Burisch,Gediminas Kiudelis,Limas Kupčinskas,Hendrika Adriana Linda Kievit,Karina Winther Andersen,Vibeke Charlotte Andersen,Riina Salupere,Natalia Konstantinovich Pedersen,Jens Kjeldsen,Renata D'Incà,Daniela Valpiani,Doron Schwartz,Selwyn H. Odes,Jóngerð Olsen,Kári Rubek Nielsen,Zsuzsanna Végh,Peter Laszlo Lakatos,Alina Toca,Svetlana Turcan,Konstantinos H Katsanos
出处
期刊:Gut [BMJ]
卷期号:68 (3): 423-433 被引量:324
标识
DOI:10.1136/gutjnl-2017-315568
摘要

OBJECTIVE: The Epi-IBD cohort is a prospective population-based inception cohort of unselected patients with inflammatory bowel disease from 29 European centres covering a background population of almost 10 million people. The aim of this study was to assess the 5-year outcome and disease course of patients with Crohn's disease (CD). DESIGN: Patients were followed up prospectively from the time of diagnosis, including collection of their clinical data, demographics, disease activity, medical therapy, surgery, cancers and deaths. Associations between outcomes and multiple covariates were analysed by Cox regression analysis. RESULTS: In total, 488 patients were included in the study. During follow-up, 107 (22%) patients received surgery, while 176 (36%) patients were hospitalised because of CD. A total of 49 (14%) patients diagnosed with non-stricturing, non-penetrating disease progressed to either stricturing and/or penetrating disease. These rates did not differ between patients from Western and Eastern Europe. However, significant geographic differences were noted regarding treatment: more patients in Western Europe received biological therapy (33%) and immunomodulators (66%) than did those in Eastern Europe (14% and 54%, respectively, P<0.01), while more Eastern European patients received 5-aminosalicylates (90% vs 56%, P<0.05). Treatment with immunomodulators reduced the risk of surgery (HR: 0.4, 95% CI 0.2 to 0.6) and hospitalisation (HR: 0.3, 95% CI 0.2 to 0.5). CONCLUSION: Despite patients being treated early and frequently with immunomodulators and biological therapy in Western Europe, 5-year outcomes including surgery and phenotype progression in this cohort were comparable across Western and Eastern Europe. Differences in treatment strategies between Western and Eastern European centres did not affect the disease course. Treatment with immunomodulators reduced the risk of surgery and hospitalisation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
微风无起发布了新的文献求助10
1秒前
1秒前
简单完成签到 ,获得积分10
1秒前
2秒前
zqh发布了新的文献求助10
2秒前
3秒前
liu完成签到,获得积分10
3秒前
Ava的应助被gulugulugulug采纳,获得10
4秒前
兮尔发布了新的文献求助10
4秒前
灵巧元霜完成签到,获得积分10
5秒前
小马甲的应助被酷炫的可乐采纳,获得10
6秒前
小画发布了新的文献求助10
6秒前
科研通AI65的应助被1900采纳,获得10
7秒前
molihuakai的应助被之之采纳,获得10
8秒前
9秒前
Kiki完成签到 ,获得积分20
12秒前
ChangZhenglee完成签到,获得积分20
12秒前
Maestro_S的应助被Arden采纳,获得10
12秒前
12秒前
额特别发布了新的文献求助10
13秒前
阔扩完成签到 ,获得积分10
13秒前
14秒前
科研通AI6.3的应助被巧克力采纳,获得10
15秒前
15秒前
回望发布了新的文献求助10
16秒前
16秒前
nmd323发布了新的文献求助10
17秒前
爱吃香菜完成签到,获得积分10
17秒前
骞骞完成签到,获得积分10
18秒前
18秒前
今后的应助被帅气的白风采纳,获得10
19秒前
20秒前
李健的小迷弟的应助被兮尔采纳,获得10
20秒前
欧耶发布了新的文献求助10
20秒前
香蕉觅云的应助被雨花石采纳,获得10
21秒前
21秒前
22秒前
Layman发布了新的文献求助10
22秒前
星遨关注了科研通微信公众号
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177802
求助须知:如何正确求助?哪些是违规求助? 9568632
关于积分的说明 21799933
捐赠科研通 7772424
什么是DOI,文献DOI怎么找? 3432505
关于科研通互助平台的介绍 2556698
邀请新用户注册赠送积分活动 2478055